Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?
Methodist Debakey Cardiovasc J
; 13(2): 73-75, 2017.
Article
em En
| MEDLINE
| ID: mdl-28740586
ABSTRACT
This is a case of a 54-year-old female with a history of mechanical aortic valve replacement who presented in cardiogenic shock. Her primary care provider started her on rivaroxaban for anticoagulation therapy. An urgent transesophageal echocardiogram revealed a significant gradient and thrombosis on one leaflet of the valve that was immobile. Given that she was not a surgical candidate, she underwent thrombolysis. However, she later died due to complications from the thrombotic valve. The utility of target-specific oral anticoagulants has yet to be established in clinical practice.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Valva Aórtica
/
Estenose da Valva Aórtica
/
Trombose
/
Próteses Valvulares Cardíacas
/
Implante de Prótese de Valva Cardíaca
/
Inibidores do Fator Xa
/
Rivaroxabana
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article